Pharmaceutical Hot Melt Extrusion Market is Expected to Witness Highest Growth During 2016 - 2024

Global Pharmaceutical Hot Melt Extrusion Market: Overview
This report provides forecast and analysis of the pharmaceutical hot melt extrusion market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn) and volume (units). The report also includes macroeconomic indicators along with an outlook on hot melt extrusion equipment consumption globally. It includes drivers and restraints of the market and their impact on each region during the forecast period.
This 164 page report gives readers a comprehensive overview of the pharmaceutical hot melt extrusion market. Browse through 18 data tables and 99 figures to unlock the hidden opportunities in this market:
http://www.transparencymarketresearch.com/pharmaceutical-hot-melt-extrusion-market.html
The report also comprises the study of current issues with end users and opportunities for extruder manufacturers. It also includes detailed pricing analysis by product type and value chain analysis with a list of vendors and industry stakeholders at each node in the value chain. In order to provide users of this report with comprehensive view of the market, we have included detailed competitiveness analysis and company players with unique selling propositions. The dashboard provides detailed comparison of hot melt extruder manufacturers on parameters such as collective market share and geographic concentration. The study encompasses market attractiveness analysis, by product, by end users and region.
Global Pharmaceutical Hot Melt Extrusion Market: Scope of the Study
The report includes revenue generated from sales of hot melt extruders in all regions and important countries in these regions. By product, the global market has been segmented into twin screw extruder, single screw extruder, laboratory extruders and RAM extruders. On the basis of end users, the global market is segmented into research laboratories, contract manufacturing organizations and pharma companies. On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market numbers have been estimated based on average procurement of new units and average pricing of hot melt extruders by product type and the revenue is derived through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The pharmaceutical hot melt extrusion market has been analyzed based on expected demand. Prices considered for the calculation of revenue are average regional prices obtained through primary quotes from numerous regional hot melt extruder manufacturers and distributors. Most of the key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving pharmaceutical hot melt extrusion market during 2016 -2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19961
Regional demand patterns have been considered while estimating the market for various end users of hot melt extrusion in different regions. Top-down approach has been used to estimate the hot melt extrusion market by regions. Market numbers for global products have been derived using the bottom-up approach, which is cumulative of each region’s demand. Company-level market share has been derived on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates. A number of primary and secondary sources were consulted during the course of the study. Secondary sources include Factiva, NCBI, Google books, company annual reports, websites, and publications.
Companies Mentioned in the Report
The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the players in the global pharmaceutical hot melt extrusion market includes Baker Perkins Limited, Coperion GmbH, Gabler GmbH & Co. KG, Leistritz AG, Milacron Holdings Corp., Thermo Fisher Scientific, Inc., and Xtrutech Ltd.

Pharmaceutical Hot Melt Extrusion Market By Analysis of Major Industry Segments 2024

Global Pharmaceutical Hot Melt Extrusion Market: Snapshot

The global market for pharmaceutical hot melt extrusion has gained a significant momentum, thanks to the versatile usage of the extrudate. The upswing in the popularity of hot melt extrusion, on account of the increasing awareness among consumers regarding the benefits it offers compared to the conventional processing techniques, such as reduced time to market and optimized product efficiency, is also supporting the growth of this market substantially.

On the other hand, the rising concerns over the quality and the non-compliance of regulatory requirements have been restraining the market’s progression. Apart from this, the inadequacy of the formulation due to the properties of API and incompetence in delivering on-time supplies may also restrict this market from growing steadily in the near future.

This 164 page report gives readers a comprehensive overview of the pharmaceutical hot melt extrusion market. Browse through 18 data tables and 99 figures to unlock the hidden opportunities in this market:

http://www.transparencymarketresearch.com/pharmaceutical-hot-melt-extrusion-market.html

The opportunity in the global market for pharmaceutical hot melt extrusion is likely to increase from a value of US$26.6 mn in 2015 to US$36.4 mn by 2024, swelling at a CAGR of 3.90% during the period from 2016 to 2024. In terms of volume, the market is expected to expand at a CAGR of more than 4.7% over the same period of time.

Strong Presence of Established Players to Ensure North America’s Dominance

On the regional front, the worldwide market for pharmaceutical hot melt extrusion has been categorized into North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. With a share of nearly 38%, North America led the global market in 2015. Thanks to the presence of a number of established players, this regional market is likely to continue to dominate over the next few years.

Europe has also been witnessing steady growth in its market for pharmaceutical hot melt extrusion and is expected to remain so due to the high demand for improved medical equipment and the increasing adoption of extruders. However, it is Asia Pacific, which will exhibit the most prominent growth rate over the forthcoming years.

The increasing research and development initiatives and the improving situation of the healthcare facilities in emerging economies, such as China, India, and Japan, Asia Pacific is likely to boost the Asia Pacific market for pharmaceutical hot melt extrusion in the near future. The increasing standard of medical and healthcare infrastructure and the rising number of government initiatives is also projected to reflect positively on this regional market in the years to come.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving pharmaceutical hot melt extrusion market during 2016 -2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19961

Demand for Twin Screw Extruders to Remain High

Based on the type of products, the global pharmaceutical hot melt extrusion market is classified into single screw extruder, twin screw extruder, laboratory extruder, and RAM extruder. Among these, the twin screw extruders segment is the key contributor to this market currently and is anticipated to remain enjoying most prominent demand over the coming years. Laboratory extruders, among other products, are likely to demonstrate a greater rate of demand in the near future.

At the forefront of the global pharmaceutical hot melt extrusion market are Baker Perkins Ltd., Coperion GmbH, Gabler GmbH & Co. KG, Leistritz AG, Milacron Holdings Corp., Thermo Fisher Scientific Inc., and Xtrutech Ltd.

Pharmaceutical Hot Melt Extrusion Market 2016 - Industry Perspective and Comprehensive Analysis 2024

According to a new research report by Transparency Market Research (TMR), the degree of competition in the global pharmaceutical hot melt extrusion market is very high. The presence of a large number of participants characterizes the market, which demonstrates a fragmented landscape. Led by Leistritz AG, Milacron Holdings Corp., Xtrutech Ltd., Coperion GmbH, and Gabler GmbH & Co. KG, the market is expected to continue with intense rivalry between them in the near future. The leading players are likely to invest heavily in R&D initiatives over the years to come, in order to meet the demand of consumers by offering innovative products, states the report.

 TMR estimates the opportunity in the global market for pharmaceutical hot melt extrusion, which was worth US$26.6 mn in 2015, to expand at a CAGR of 3.90% between 2016 and 2024 and reach a value of US$36.4 mn by the end of the period of the forecast. During the same period of time, the market volume is anticipated to swell at a CAGR of more than 4.7%, boosting the market significantly. Twin screw extruders have emerged as the most valued products in this market and is predicted to continue to enjoy a high demand over the forthcoming years.

 This 164 page report gives readers a comprehensive overview of the pharmaceutical hot melt extrusion market. Browse through 18 data tables and 99 figures to unlock the hidden opportunities in this market:

http://www.transparencymarketresearch.com/pharmaceutical-hot-melt-extrusion-market.html

 On Backdrop of Large Pool of Leading Players, North America to Retain its Lead

 The worldwide market for pharmaceutical hot melt extrusion boasts of a widespread presence across North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. In this research report, a regional analysis of this market has also been provided to the readers. According to the study, North America led the global market with a share of nearly 38% in 2015. Researchers predicts this regional market to maintain its dominance throughout the forecast period, thanks to the presence of a large pool of established players, especially in the U.S.

 The Europe market for pharmaceutical hot melt extrusion has also been witnessing steady growth and is predicted to continue doing so in the near future on account of the increasing demand for improved medical equipment and the growing adoption of extruders. Asia Pacific, However, will present the most lucrative growth opportunities for players in this market over the forthcoming years, thanks to rising number of research and development initiatives and the improving situation of the healthcare facilities in emerging economies, such as China, India, and Japan. The heightening standard of medical and healthcare infrastructure and the increase in government initiatives is also expected to impact this regional market in the forthcoming years.

 Request a sample of this report to know what opportunities will emerge in the rapidly evolving pharmaceutical hot melt extrusion market during 2016 -2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19961

 Rising Awareness among Consumers to Reflect Positively on Demand for Pharmaceutical Hot Melt Extrusion

 According to an analyst at TMR, “the rising awareness regarding the benefits hot melt extrusion offers over traditional processing techniques, is the key factor behind the significant growth of the global pharmaceutical hot melt extrusion market.” The operating parameters in hot melt extrusion can be easily changed, the segmented screw elements allow agitator designs to be easily optimized to suit a particular application, and the die plates can also be easily exchanged to alter the extrudate diameter. All these characteristics are having a positive influence on the demand for pharmaceutical hot melt extrusion, leading to a significant rise in this market. However, the rising concerns over the quality and the non-compliance of regulatory requirements may limit the growth of this market to some extent over the next few years, notes the research study.

 The study presented here is based on a report by Transparency Market Research (TMR), titled “Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Pharmaceutical Hot Melt Extrusion Market is expected to reach to US$36.4 mn by 2024

According to a new research report by Transparency Market Research (TMR), the degree of competition in the global pharmaceutical hot melt extrusion market is very high. The presence of a large number of participants characterizes the market, which demonstrates a fragmented landscape. Led by Leistritz AG, Milacron Holdings Corp., Xtrutech Ltd., Coperion GmbH, and Gabler GmbH & Co. KG, the market is expected to continue with intense rivalry between them in the near future. The leading players are likely to invest heavily in R&D initiatives over the years to come, in order to meet the demand of consumers by offering innovative products, states the report.

TMR estimates the opportunity in the global market for pharmaceutical hot melt extrusion, which was worth US$26.6 mn in 2015, to expand at a CAGR of 3.90% between 2016 and 2024 and reach a value of US$36.4 mn by the end of the period of the forecast. During the same period of time, the market volume is anticipated to swell at a CAGR of more than 4.7%, boosting the market significantly. Twin screw extruders have emerged as the most valued products in this market and is predicted to continue to enjoy a high demand over the forthcoming years.

Read Full Report: http://www.transparencymarketresearch.com/pharmaceutical-hot-melt-extrusion-market.html

On Backdrop of Large Pool of Leading Players, North America to Retain its Lead

The worldwide market for pharmaceutical hot melt extrusion boasts of a widespread presence across North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. In this research report, a regional analysis of this market has also been provided to the readers. According to the study, North America led the global market with a share of nearly 38% in 2015. Researchers predicts this regional market to maintain its dominance throughout the forecast period, thanks to the presence of a large pool of established players, especially in the U.S.

The Europe market for pharmaceutical hot melt extrusion has also been witnessing steady growth and is predicted to continue doing so in the near future on account of the increasing demand for improved medical equipment and the growing adoption of extruders. Asia Pacific, However, will present the most lucrative growth opportunities for players in this market over the forthcoming years, thanks to rising number of research and development initiatives and the improving situation of the healthcare facilities in emerging economies, such as China, India, and Japan. The heightening standard of medical and healthcare infrastructure and the increase in government initiatives is also expected to impact this regional market in the forthcoming years.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19961

Rising Awareness among Consumers to Reflect Positively on Demand for Pharmaceutical Hot Melt Extrusion

According to an analyst at TMR, “the rising awareness regarding the benefits hot melt extrusion offers over traditional processing techniques, is the key factor behind the significant growth of the global pharmaceutical hot melt extrusion market.” The operating parameters in hot melt extrusion can be easily changed, the segmented screw elements allow agitator designs to be easily optimized to suit a particular application, and the die plates can also be easily exchanged to alter the extrudate diameter. All these characteristics are having a positive influence on the demand for pharmaceutical hot melt extrusion, leading to a significant rise in this market. However, the rising concerns over the quality and the non-compliance of regulatory requirements may limit the growth of this market to some extent over the next few years, notes the research study.

The study presented here is based on a report by Transparency Market Research (TMR), titled “Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”